Clinical Trials Browser

Phase 4 × Gefitinib × Clear all

NCT02299765 2017-11-27

Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC

Phase 4 Terminated

Non-small Cell Lung Cancer Metastatic

NCT03264794 2017-08-29

the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01203917 2017-01-02

IFUM

Phase 4 Completed

1,060 enrolled 14 charts

Caucasian Patients With EGFR Mutation Positive Advanced NSCLC

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00770588 2016-02-08

INFORM

Phase 4 Completed

296 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00536107 2013-10-01

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Terminated

14 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00608868 2012-09-28

SELINE

Phase 4 Completed

156 enrolled 14 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung